By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Chugai Pharmaceutical Co., Ltd. (Japan) 

1-9, Kyobashi 2-chome

Chuo-ku  Tokyo  104-8301  Japan
Phone: 81-3-3281-6611 Fax: 81-3-3281-2828


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





Company News
Helsinn Group And Marketing Enter Into Agreement For Marketing Rights Of Netupitant-Palonosetron Fixed-Dose Combination (NEPA) In The UK And Ireland And For Palonosetron Monotherapy In The UK 7/17/2014 9:14:54 AM
Chugai Pharmaceutical Co., Ltd. (Japan) Invests $30 Million To Build China Marketing/Distribution 12/30/2013 1:29:24 PM
Roche (RHHBY) Has No Plan to Sell Chugai Pharmaceutical Co., Ltd. (Japan) Stake 4/12/2013 7:54:53 AM
Chugai Pharmaceutical Co., Ltd. (Japan) and Debiopharm Announce an Exclusive License Agreement for Anti-Cancer Agent, FF284 1/8/2013 10:48:22 AM
Chugai Pharmaceutical Co., Ltd. (Japan) to Invest $150 Million in Singapore 7/17/2012 7:47:47 AM
Chugai Pharmaceutical Co., Ltd. (Japan) Standardizes on Medidata Rave Clinical Technology 1/31/2011 10:52:14 AM
Chugai Pharmaceutical Co., Ltd. (Japan) Grants Circadian Technologies Limited (CIR.AX) Worldwide Licence to Its VEGF-D Intellectual Property Estate 1/14/2011 1:20:08 PM
Chugai Pharmaceutical Co., Ltd. (Japan) of Japan Grants Circadian Worldwide Licence to its Vegf-D Intellectual Property 1/13/2011 10:23:35 AM
A-CUBE Announces Agreement With Chugai Pharmaceutical Co., Ltd. (Japan) 12/16/2010 9:36:00 AM
Antitope Announces EpiScreen Collaboration with Chugai Pharmaceutical Co., Ltd. (Japan) 10/11/2010 2:13:53 PM
1234567
//-->